Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Angstron Materials is a specialized nanomaterials company that focuses on the large-scale production of graphene and graphene-related products. While primarily known for energy storage and thermal management applications, the company leverages its advanced materials platform for life science applications, including biosensors, medical imaging, and drug delivery systems. Their technology utilizes the unique electrical and mechanical properties of graphene to enhance the sensitivity of diagnostic tools and the efficiency of therapeutic delivery. As a subsidiary of Global Graphene Group, Angstron Materials provides high-purity graphene oxide and nanoplatelets to researchers and commercial partners in the healthcare and biotechnology sectors.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Angstron Materials.